Patient P-01862

Synthetic patientNBL-101 · Day 98 · 25–34 · M · baseline S04Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Improving

GI state

Improving

Inflammatory state

Improving

Nutritional resilience

Improving

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S04

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity-15
Inflammatory activity-11
GI instability-7
Nutritional resilience+6
Treatment adherence+4

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

5.1/100

improving · -6.9 vs previous 14 d

Toxicity

Blood

5.4/100

improving · -9.7 vs previous 14 d

Sleep quality

Wearable

45/100

improving · +8.3 vs previous 14 d

Energy level

Daily log

7.4/10

improving · +0.6 vs previous 14 d

Stress level

Daily log

3/10

improving · -0.4 vs previous 14 d

Steps

Wearable

6,787

improving · +398 vs previous 14 d

Adherence

Companion

93.9 %

stable · -0.3 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 106 from the failing basin, 19 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Daily walks resumed
perturbation · steering +3.3

Main detractors to watch

Simple carbohydrates
perturbation · steering -8.1
Low microbial diversity
hidden · steering -7.7
Enterobacteriaceae elevated
hidden · steering -7.4
Alcohol
perturbation · steering -7.2
Alcohol
detractor · GI +5 next day
Simple carbohydrates
detractor · GI +4.7 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
+5detractor · 95%
Simple carbohydrates
+4.7detractor · 95%
Dietary fat load
+2.2no signal · 48%
Insoluble fibre
+1.7no signal · 30%
Spicy / capsaicin
-0.5no signal · 15%
Histamine load
-0.4no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↑20
- WearableShort sleep window

DNA

Fictional pharmacogenomic panel

CYP2D6 Intermediate metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 2.9 · butyrate capacity 63/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 59 ms
Sleep: 6.3 h
Steps: 6,193
Resting HR: 56 bpm

Daily log: GI score 5, nutritional resilience 76, adherence 94.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01766	41%	S05	AD-05	no change	90
P-01804	24%	S19	AD-05	improved	61
P-01541	23%	S09	AD-05	no change	43
P-01377	22%	S11	AD-05	no change	42
P-01677	40%	S05	BR-03	no change	86
P-01329	38%	S08	BR-03	improved	79
P-01495	34%	S07	BR-03	improved	85
P-01689	23%	S13	BR-03	no change	50
P-01654	39%	S08	CR-01	improved	85
P-01430	23%	S05	CR-01	improved	54
P-01479	35%	S15	DT-01	improved	84
P-01855	32%	S04	DT-01	improved	73